CCGs failing to offer access to ‘flash’ glucose monitoring devices

CCGs failing to offer access to ‘flash’ glucose monitoring devices Only about 3-5% of patients with type 1 diabetes in England are prescribed the FreeStyle Libre glucose sensor on the NHS as many clinical commissioning groups (CCGs) are ‘paying lip service’ to offering access to the device, a BMJ investigation* has found. Experts told the report’s authors that this postcode lottery means that tens of thousands of patients are being denied the potential lifestyle and health benefits of flash glucose monitoring. OnMedica